Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Martin

Showing results (701-710 of 842) with videos related to

Pageof 85
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 4, 2025
Diagnosis and treatment of radiation induced pneumonitis in patients with lung cancer: An ESTRO clinical practice guidelineDirk De Ruysscher, Els Wauters, Verena Jendrossek, et al.
Blood|April 4, 2002
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host diseasePaul A Carpenter, Frederick R Appelbaum, Lawrence Corey, et al.
The Lancet. Diabetes & Endocrinology|August 5, 2018
Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trialWiebke Birnbaum, Louise Marshall, Ralf Werner, et al.
Neuroendocrinology|January 16, 2023
A Prospective Analysis of the Metyrapone Short Test Using Targeted and Untargeted MetabolomicsAnna Katharina Seoudy, Kristina Schlicht, Alexandra Kulle, et al.
European Journal of Endocrinology|February 19, 2013
Five novel mutations in the SCNN1A gene causing autosomal recessive pseudohypoaldosteronism type 1Maik Welzel, Leyla Akin, Anja Büscher, et al.
The Lancet. Gastroenterology & Hepatology|June 4, 2017
Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trialAnnette Bruchfeld, David Roth, Paul Martin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2025
Recent Trends of Incidence, Mortality, Treatment, and Overall Survival of Hepatocellular Carcinoma in the United StatesYi-Te Lee, Jasmine J Wang, Pojsakorn Danpanichkul, et al.
Hepatology (Baltimore, Md.)|June 29, 2007
Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: the hepatitis B quality of life instrument, version 1.0Brennan M R Spiegel, Roger Bolus, Steven Han, et al.
The Lancet Regional Health. Europe|September 15, 2022
Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort studyPaul Martin, Sarah Gleeson, Candice L Clarke, et al.
Clinical Colorectal Cancer|September 11, 2020
Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International ExpertsThomas Steffen, Janina Eden, Lana Bijelic, et al.
Pageof 85

Showing results (701-710 of 842) with videos related to

Sort By:
Pageof 85
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 4, 2025
Diagnosis and treatment of radiation induced pneumonitis in patients with lung cancer: An ESTRO clinical practice guidelineDirk De Ruysscher, Els Wauters, Verena Jendrossek, et al.
Blood|April 4, 2002
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host diseasePaul A Carpenter, Frederick R Appelbaum, Lawrence Corey, et al.
The Lancet. Diabetes & Endocrinology|August 5, 2018
Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trialWiebke Birnbaum, Louise Marshall, Ralf Werner, et al.
Neuroendocrinology|January 16, 2023
A Prospective Analysis of the Metyrapone Short Test Using Targeted and Untargeted MetabolomicsAnna Katharina Seoudy, Kristina Schlicht, Alexandra Kulle, et al.
European Journal of Endocrinology|February 19, 2013
Five novel mutations in the SCNN1A gene causing autosomal recessive pseudohypoaldosteronism type 1Maik Welzel, Leyla Akin, Anja Büscher, et al.
The Lancet. Gastroenterology & Hepatology|June 4, 2017
Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4-5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trialAnnette Bruchfeld, David Roth, Paul Martin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 20, 2025
Recent Trends of Incidence, Mortality, Treatment, and Overall Survival of Hepatocellular Carcinoma in the United StatesYi-Te Lee, Jasmine J Wang, Pojsakorn Danpanichkul, et al.
Hepatology (Baltimore, Md.)|June 29, 2007
Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: the hepatitis B quality of life instrument, version 1.0Brennan M R Spiegel, Roger Bolus, Steven Han, et al.
The Lancet Regional Health. Europe|September 15, 2022
Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort studyPaul Martin, Sarah Gleeson, Candice L Clarke, et al.
Clinical Colorectal Cancer|September 11, 2020
Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International ExpertsThomas Steffen, Janina Eden, Lana Bijelic, et al.
Pageof 85